Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 374.81% | 100.93% | 81.75% | -108.77% | 49.48% |
| Total Depreciation and Amortization | 1.40% | 1.18% | 3.34% | -14.01% | 7.12% |
| Total Amortization of Deferred Charges | -18.94% | -46.03% | -28.16% | -27.50% | -1.50% |
| Total Other Non-Cash Items | 121.38% | -98.88% | 4,701.71% | -278.16% | -137.41% |
| Change in Net Operating Assets | 53.05% | -44.89% | -24.21% | -28.04% | 616.12% |
| Cash from Operations | 134.63% | 155.66% | 187.08% | -76.71% | 81.93% |
| Capital Expenditure | 32.40% | 38.91% | 48.66% | 41.84% | 48.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -1,962.32% | -- | -183.58% | -102.24% |
| Cash from Investing | 34.27% | -99.94% | 58.66% | -721.53% | -49.94% |
| Total Debt Issued | -96.70% | 143.41% | -18.20% | 40.40% | 2,669.27% |
| Total Debt Repaid | 89.25% | -56.65% | -133.46% | 37.19% | -1,377.16% |
| Issuance of Common Stock | -- | -- | -20.59% | -- | -- |
| Repurchase of Common Stock | -0.50% | 52.02% | 35.63% | 94.74% | -16.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 59.80% | -- | -- | -- |
| Cash from Financing | -351.81% | 96.13% | -76.55% | 440.45% | 48.56% |
| Foreign Exchange rate Adjustments | -99.38% | -108.64% | -132.92% | 119.83% | -110.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.18% | -5.68% | 124.22% | -90.83% | 18,165.82% |